Please check your internet connection and try again.
# Methycobalime (methylcobalamin)
## Overview
Methycobalime, containing methylcobalamin, is an active, coenzyme form of vitamin B12. It is essential for DNA synthesis, red blood cell formation, and neurological function.
## Primary Indications
* Vitamin B12 deficiency (e.g., pernicious anemia, malabsorption syndromes, dietary insufficiency).
* Peripheral neuropathy (neuropathic pain).
## Adult Dosing
* **Vitamin B12 Deficiency:** Dosing varies based on severity and route. Parenteral administration is common for severe deficiency or malabsorption. Oral doses can range from 1000 mcg to 2000 mcg daily, often given with intrinsic factor if malabsorption is suspected. Intramuscular or subcutaneous injections typically range from 1000 mcg daily to weekly, then monthly for maintenance.
* **Peripheral Neuropathy:** Common oral doses are 500 mcg to 1500 mcg daily.
## Pediatric Dosing
* Dosing for pediatric patients is not well-established and should be determined by a specialist based on age, weight, and clinical indication.
## Dose Adjustments
* No dose adjustments are typically required for renal or hepatic impairment, as methylcobalamin is a vitamin. However, the underlying cause of deficiency may require specific management.
## Contraindications
* Hypersensitivity to cobalt, vitamin B12, or any component of the formulation.
## Adverse Effects
* Generally well-tolerated.
* Rare: hypersensitivity reactions (rash, pruritus, anaphylaxis), acneiform eruptions, diarrhea.
## Key Drug Interactions
* **Metformin:** May reduce vitamin B12 absorption.
* **Proton Pump Inhibitors (PPIs) and H2 Receptor Antagonists:** May reduce vitamin B12 absorption with long-term use.
* **Chloramphenicol:** Can interfere with the hematopoietic response to vitamin B12.
## Monitoring
* Serum vitamin B12 levels.
* Complete blood count (CBC) to assess for hematological response.
* Symptom assessment for neurological improvement.
## Clinical Pearls
* Methylcobalamin is the active form of B12 and bypasses the need for conversion by the liver, potentially offering advantages in certain conditions.
* Parenteral administration is preferred for severe deficiencies or conditions affecting absorption (e.g., pernicious anemia, gastric bypass).
* Monitor for adequate response; if symptoms persist despite appropriate dosing, consider compliance issues or alternative diagnoses.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider for any health concerns or before making any treatment decisions.
